# Safety, Tolerability, Pharmacodynamics and Efficacy Study of TAB08 in Patients With Rheumatoid Arthritis

> **NCT01990157** · PHASE1,PHASE2 · COMPLETED · sponsor: **Theramab LLC** · enrollment: 18 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** TAB08

## Key facts

- **NCT ID:** NCT01990157
- **Lead sponsor:** Theramab LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-11
- **Primary completion:** 2015-12
- **Final completion:** 2017-02
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2017-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01990157

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01990157, "Safety, Tolerability, Pharmacodynamics and Efficacy Study of TAB08 in Patients With Rheumatoid Arthritis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01990157. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*